Exploring T-DXd in HER2-Positive Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerExploring T-DXd in HER2-Positive Breast Cancer Treatment
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
On the Frontlines of Metastatic Breast CancerDESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerModern Approaches to Long-Term Metastatic Breast Cancer Care
Genomic Profile of ER+ HER2- Metastatic Invasive Lobular Carcinoma
Project Oncology®Genomic Profile of ER+ HER2- Metastatic Invasive Lobular Carcinoma
Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
Project Oncology®Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
New Insights Into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Clinician's RoundtableNew Insights Into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
- advertisement
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
CME/CEHER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
CME/CEThe Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
CME/CEWhy Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
CME/CEParallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
- advertisement
MIRASOL Insights in PROC: A Biomarker-Driven Approach
Project Oncology®MIRASOL Insights in PROC: A Biomarker-Driven Approach
Advancing Care in Pretreated HR+/HER2- mBC
Medical Industry FeatureAdvancing Care in Pretreated HR+/HER2- mBC
Supportive Care in Patients with Pretreated HR+/HER2- mBC
Medical Industry FeatureSupportive Care in Patients with Pretreated HR+/HER2- mBC
The Unmet Need in 1L HR+/HER2− Advanced Breast Cancer
Medical Industry FeatureThe Unmet Need in 1L HR+/HER2− Advanced Breast Cancer
New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Medical Industry FeatureNew 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry FeatureClinical Decision Making for HER2 Low Metastatic Breast Cancer
- 01/05/2026
- 01/05/2026
- 01/02/2026
- 01/02/2026
- 01/02/2026
- 01/01/2026